| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 03/10/2005 | WO2005021497A2 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones |
| 03/10/2005 | US20050054551 Alkyl-and/or alkylene oligoglycoside betaine ester quaternaries |
| 03/09/2005 | EP1511756A2 Gangliosides with a modified acyl function |
| 03/09/2005 | EP1404691B1 Method for producing peracylated 1-o-glycosides |
| 03/09/2005 | EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 03/09/2005 | EP0817627B1 Protein kinase c inhibitors |
| 03/08/2005 | US6863737 Crystalline mixture solid containing maltitol and preparation therefor |
| 03/03/2005 | WO2005019238A1 Novel azalide and azalactam derivatives and process for the production of the same |
| 03/03/2005 | WO2005019237A1 Novel sulfenamides |
| 03/03/2005 | WO2005019236A1 Novel sulfenamide oxides |
| 03/03/2005 | US20050049283 Compounds that inhibit factor xa activity |
| 03/03/2005 | US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis |
| 03/03/2005 | US20050048149 Controlling weight, obesity; antidiabetic agents; using apple juice extract |
| 03/03/2005 | CA2535802A1 Novel sulfenamides |
| 03/03/2005 | CA2535800A1 Novel sulfenamide oxides |
| 03/02/2005 | EP1510521A1 Sugar-substituted 2-Azetidinones useful as hypocholesterolemic agents |
| 03/02/2005 | EP1165563B1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 03/02/2005 | CN1191264C Uridine derivatives as antibiotics |
| 03/01/2005 | US6861514 The folate can be attached via the alpha - or gamma -carboxylate, optionally through a linking group. |
| 03/01/2005 | US6861512 Separation of olefinic isomers |
| 03/01/2005 | US6861410 Immunological adjuvant compositions |
| 02/24/2005 | WO2005017180A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 02/24/2005 | US20050043248 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/24/2005 | CA2533924A1 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 02/23/2005 | EP1507541A2 Inhibitors and methods of use thereof |
| 02/23/2005 | CN1583686A Preparation of oligomer and monomer from tannin by catalytic hydrogen degradation |
| 02/22/2005 | US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858588 Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera |
| 02/22/2005 | CA2259784C Quinolinone glycoside, production process, and anti-allergic agent |
| 02/17/2005 | WO2005015155A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 02/17/2005 | WO2005014608A2 Process for preparing maltitol enriched products |
| 02/17/2005 | WO2004099135A3 Hiv prodrugs cleavable by cd26 |
| 02/17/2005 | WO2004092329A3 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 02/17/2005 | US20050038126 Administering mammal a bicyclo [3.2.1]octan in a double ring system having kaurene structure such as steviol, isosteviol and stevioside; synergistic mixture with soy protein, and/or fiber and/or isoflavone |
| 02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia |
| 02/17/2005 | US20050038008 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 02/17/2005 | CA2529508A1 Process for preparing maltitol enriched products |
| 02/16/2005 | EP1506221A2 Fap-activated anti-tumor prodrugs |
| 02/16/2005 | EP1506213A1 An antimicrobial agent |
| 02/16/2005 | EP1506211A1 C-aryl glucoside sglt2 inhibitors and method |
| 02/16/2005 | EP1505953A2 Novel polyol-glycoside compositions for the skin |
| 02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 02/15/2005 | US6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 02/10/2005 | WO2005012321A1 Novel compounds |
| 02/10/2005 | WO2005012320A2 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/10/2005 | WO2005012242A2 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 02/10/2005 | WO2004108743A3 Support comprising immobilised carbohydrate molecules and its use |
| 02/10/2005 | US20050032742 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 02/10/2005 | US20050032712 Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides |
| 02/10/2005 | DE10247476B4 Verfahren zur Anreicherung und Isolierung von Oregonin Method for the enrichment and isolation of Oregonin |
| 02/10/2005 | CA2549022A1 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 02/10/2005 | CA2533892A1 Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds |
| 02/10/2005 | CA2528592A1 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1503768A1 Inositol pyrophosphates, and methods of use thereof |
| 02/09/2005 | EP1200441B1 Process for making morphine-6-glucuronide and its analogues using haloglucuronate ester intermediates |
| 02/09/2005 | CN1188424C Crystallization of doxorubicin hydrochloride |
| 02/09/2005 | CN1188134C Preparation having increased in vivo tolerability |
| 02/08/2005 | US6852878 Treating inflammatory disorders, cardiovascular diseases, occular diseases, autoimmune diseases, neurological disorders, and cancer. The compounds also can be used to treat hyperlipidemia and/or hypercholesterolemia. |
| 02/08/2005 | US6852866 For use as enzyme inhibitors and chemical intermediates; combinatorial libraries |
| 02/08/2005 | US6852342 Solvent extraction of a simmondsin compoundfrom a jojoba plant; used as a dietary supplement for use in a weight control regiment |
| 02/03/2005 | WO2005009597A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 02/02/2005 | EP1501844A1 Disaccharides for drug discovery |
| 02/02/2005 | CN1575297A Stabilization of amrubicin hydrochloride |
| 02/02/2005 | CN1575296A Use of alkylpolyglycosides as emulsifying agents for the preparation oil-in-water emulsions containing mineral pigments or fillers and the oil-in-water emulsions containing such alkylpolyglycosides |
| 02/01/2005 | US6849607 Galectin recognized photosensitizers for photodynamic therapy |
| 01/27/2005 | WO2005007667A1 Curcuminoid glycoside and process for producing the same |
| 01/27/2005 | WO2005007666A1 Novel method for producing dialdehyde and related compounds |
| 01/27/2005 | WO2005007665A2 Lincomycin derivatives possessing antibacterial activity |
| 01/27/2005 | WO2005007172A1 Glycoside-containing liposome |
| 01/27/2005 | US20050020533 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 01/27/2005 | US20050019884 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019251 Administering isotope labeled water to tissue; measurement; calibration |
| 01/27/2005 | CA2528596A1 Lincomycin derivatives possessing antibacterial activity |
| 01/26/2005 | EP1499743A1 Means and methods for detecting endoglycosidase activity |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/26/2005 | EP1001961B1 Substituted tetrahydropyrane derivatives and method for producing same |
| 01/26/2005 | CN1571792A Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides |
| 01/26/2005 | CN1569871A Gene promoter of bacillus pumilus and its polynucleotide sequence |
| 01/25/2005 | CA2174209C Phosphorescent compounds for imaging tissue oxygen |
| 01/20/2005 | WO2005005449A2 Steroid modified solatrioses |
| 01/20/2005 | WO2005004805A2 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 01/20/2005 | WO2004058787A3 Fluorogenic enzyme substrates and methods of preparation |
| 01/20/2005 | US20050014937 Fibrous nano self-assemblies |
| 01/20/2005 | US20050014704 Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 01/20/2005 | CA2529358A1 Steroid modified solatrioses |
| 01/19/2005 | EP1498386A1 Microfine self-aggregate |
| 01/19/2005 | EP1497297A1 Polymorph of ascomycin derivative |
| 01/19/2005 | CN1568328A Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| 01/19/2005 | CN1568190A Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/19/2005 | CN1185247C Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 01/19/2005 | CN1185245C Quinolinone glucoside, its preparing method and antitransformation reaction agent |
| 01/19/2005 | CN1185244C Rebescensine A derivatives and preparing process thereof |
| 01/19/2005 | CN1185243C Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases |
| 01/18/2005 | US6844429 Fullerene derivative and composition comprising the same |
| 01/18/2005 | US6844346 For detection of neuraminidases; for identifying vaginal and periodontal infections; for detection of Pseudomonas aeruginosa in cystic fibrosis patients |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |